Skip to main content

Advertisement

Log in

Recombinant Anti-Müllerian Hormone (rAMH) for Stalling In Vitro Granulosa Cell Replication

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

To investigate whether recombinant AMH (rAMH) is able to decrease cellular proliferation/apoptosis in luteinized granulosa cells (GCs) through hormonal regulation, a primary culture of GCs was established from GCs obtained at time of oocyte retrieval from follicular fluid of 3 patients. Cells were seeded in well cell culture plates at a density of 100,000 cells/well in medium and treated with rAMH 20 ng/ml (rAMH group), or phosphate-buffered saline (PBS-control group), for 24 h. Total RNA was extracted from all cells, followed by cDNA synthesis and real-time RT-PCR to quantify the expression levels of AMH, AMH-R2, FSH-R, inhibin B, cell proliferation (Ki67), and apoptosis (Caspase 3). We used independent sample t test (SPSS v25) and a p < 0.05 significance. Cellular expressions of AMH, AMH-R2, FSH-R, and inhibin B were reduced greater than 50% in the rAMH group, compared with that of the the control group (p ≤ 0.005 for all). Ki67 and Caspase3 were also reduced greater than 30% in the rAMH group (p ≤ 0.001 for both). Our findings show a direct inhibitory effect of AMH on luteinized GCs’ expression of the major regulatory hormones, in addition to a significant decrease in markers of cell proliferation and apoptosis. These results confirm the inhibitory effects of AMH on follicular development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Durlinger ALL, Kramer P, Karels B, de Jong FH, Uilenbroek JTJ, Grootegoed JA, et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinol. 1999;140:5789–96.

    Article  CAS  Google Scholar 

  2. Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinol. 2001;142:4891–9.

    Article  CAS  Google Scholar 

  3. Josso N, di Clemente N, Gouedard L. Anti-Mullerian hormone and its receptors. Mol Cell Endocrinol. 2001;179:25–32.

    Article  CAS  Google Scholar 

  4. Ratteralli JL, Levi AJ, Miller BT. A prospective novel method of determining ovarian size during in vitro fertilization cycles. J Assist Reprod Genet. 2002;19:39–41.

    Article  Google Scholar 

  5. Detti L, Fletcher NM, Saed GM, Peregrin-Alvarez I, Uhlmann RA. Anti-Müllerian hormone (AMH) may stall ovarian cortex function through modulation of hormone receptors other than the AMH receptor. Reprod Sci. 2018;25:1218–23.

    Article  CAS  Google Scholar 

  6. Pellat L, Rice S, Dilaver N, et al. Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil Steril. 2011;96:1246–51.

    Article  Google Scholar 

  7. Detti L, Fletcher NM, Uhlmann RA, Peregrin-Alvarez I, Roman RA, Saed GM. Anti-Mullerian hormone (AMH) regulates ovarian cortex’s stemness potential in fresh and vitrified/thawed ovarian cortex. Minerva Ginecol. 2019;71:249–53.

    Article  Google Scholar 

  8. Detti L, Fletcher NM, Saed GM, Sweatman TW, Uhlmann RA, Pappo A, et al. Anti-Mullerian hormone (AMH) for prevention of ovarian follicle depletion after pre-pubertal ovarian cortex xenotransplantation. J Assist Reprod Genet. 2018;35:1831–41.

    Article  Google Scholar 

  9. Kano M, Sosulski AE, Zhang L, Saatcioglu HD, Wang D, Nagykery N, et al. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proc Natl Acad Sci U S A. 2017;114:E1688–97.

    Article  CAS  Google Scholar 

  10. Roness H, Spector I, Leichtmann-Bardoogo Y, Savino AM, Dereh-Haim S, Meirow D. Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects. J Assist Reprod Genet. 2019;36:1793–803.

    Article  CAS  Google Scholar 

  11. Grossman MP, Nakajima ST, Fallat ME, Siow Y. Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil Steril. 2008;89:1364–70.

    Article  CAS  Google Scholar 

  12. Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, et al. Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun. 2016;7:10055.

    Article  CAS  Google Scholar 

  13. Hu R, Wang FM, Yu L, et al. Antimüllerian hormone regulates stem cell factor expression in human granulosa cells. Fertil Steril. 2014;102:1742–50.e1.

    Article  CAS  Google Scholar 

  14. Fang Y, Lu X, Liu L, et al. Vascular endothelial growth factor induces anti-Müllerian hormone receptor 2 overexpression in ovarian granulosa cells of in vitro fertilization/intracytoplasmic sperm injection patients. Mol Med Rep. 2016;13:5157–62.

    Article  CAS  Google Scholar 

  15. Blumenfeld Z. Fertility preservation by endocrine suppression of ovarian function using gonadotropin-releasing hormone agonists: the end of the controversy? J Clin Oncol. 2018 Jul 1;36(19):1895–7.

    Article  Google Scholar 

  16. Detti L, Uhlmann RA, Lu M, et al. Goserelin fosters bone elongation, but does not prevent ovarian damage, in cyclophosphamide-treated pre-pubertal mice. Fertil Steril. 2014;101:1157–64.

    Article  CAS  Google Scholar 

  17. Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod. 2011;26:3123–9.

    Article  CAS  Google Scholar 

  18. Detti L, Norwick H, Osborne SE, et al. Anti-mullerian hormone (AMH) serum measurements reflect cycle length and ovarian follicle number in women with polycystic ovary syndrome (PCOS). Abstract Obstet Gynecol. 2015;125:110S. https://doi.org/10.1097/01.AOG.0000463620.62401.f6.

    Article  CAS  Google Scholar 

  19. Schmidt KL, Kryger-Baggesen N, Byskov AG, Andersen CY. Anti-Mullerian hormone initiates growth of human primordial follicles in vitro. Mol Cell Endocrinol. 2005;234:87–93.

    Article  CAS  Google Scholar 

  20. Kushnir VA, Seifer DB, Barad DH, Sen A, Gleicher N. Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine. J Assist Reprod Genet. 2017;34:1105–13. https://doi.org/10.1007/s10815-017-0977-4.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Detti L. Website newsletter. International Society for Fertility Preservation. Anti-Müllerian hormone (AMH) and its multiple purposes in fertility preservation. 2019. ISFP website.

Download references

Funding

This study was supported by an institutional grant (E07-3225-001) from the University of Tennessee Health Science Center, Memphis, TN.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laura Detti.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Detti, L., Abuzeid, M.I., Peregrin-Alvarez, I. et al. Recombinant Anti-Müllerian Hormone (rAMH) for Stalling In Vitro Granulosa Cell Replication. Reprod. Sci. 27, 1873–1878 (2020). https://doi.org/10.1007/s43032-020-00206-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43032-020-00206-6

Keywords

Navigation